Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]

Yousef AA, Mohamed FY, Boraey NF, et al. J Inflamm Res. 2020;13:1103— 1111. The authors have advised the affiliation list on page 1103is incorrect. The correct author list and affiliations are asfollows: Aly A Yousef, 1 Faisal Y Mohamed, 2 Naglaa F Boraey, 3Nagwa E Akeel, 4 Attia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yousef AA, Mohamed FY, Boraey NF, Akeel NE, Soliman AA, Waked NM, Hashem MIA, Shehata H, Fahmy DS, Ismael A, Ibrahim LM, Ibrahim MAM, Salem HF, Yousry SM, Osman SF, Fouad RA, Enan ET, Attia MA, Afify MR, Zeidan NMS, Nashat M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	plasminogen activator inhibitor-1 (pai-1) gene polymorphism sle children adolescents Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/99db3fce92fe4ca6878a6ba8539a2f8c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]

Ejemplares similares